| 000 | 01443 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250513121654.0 | ||
| 264 | 0 | _c19970808 | |
| 008 | 199708s 0 0 eng d | ||
| 022 | _a0163-5581 | ||
| 024 | 7 |
_a10.1080/01635589709514556 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchmelz, E M | |
| 245 | 0 | 0 |
_aSuppression of aberrant colonic crypt foci by synthetic sphingomyelins with saturated or unsaturated sphingoid base backbones. _h[electronic resource] |
| 260 |
_bNutrition and cancer _c1997 |
||
| 300 |
_a81-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _a1,2-Dimethylhydrazine |
| 650 | 0 | 4 |
_aAdenocarcinoma _xprevention & control |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aColonic Neoplasms _xprevention & control |
| 650 | 0 | 4 | _aDiet |
| 650 | 0 | 4 | _aDimethylhydrazines |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMilk _xchemistry |
| 650 | 0 | 4 |
_aPrecancerous Conditions _xchemically induced |
| 650 | 0 | 4 |
_aSphingolipids _xchemistry |
| 650 | 0 | 4 |
_aSphingomyelins _xadministration & dosage |
| 650 | 0 | 4 | _aWeight Gain |
| 700 | 1 | _aBushnev, A S | |
| 700 | 1 | _aDillehay, D L | |
| 700 | 1 | _aLiotta, D C | |
| 700 | 1 | _aMerrill, A H | |
| 773 | 0 |
_tNutrition and cancer _gvol. 28 _gno. 1 _gp. 81-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/01635589709514556 _zAvailable from publisher's website |
| 999 |
_c9180669 _d9180669 |
||